Exploratory Assessment of Oxygen Flow–Assisted Cutaneous Administration of Methotrexate for Superficial Basal Cell Carcinoma, Mycosis Fungoides, and Extramammary Paget Disease
LEBAS, Eve ; Centre Hospitalier Universitaire de Liège - CHU > Autres Services Médicaux > Service de dermatologie
CHAPELIER, Corinne ; Centre Hospitalier Universitaire de Liège - CHU > Autres Services Médicaux > Service de dermatologie
QUATRESOOZ, Pascale ; Centre Hospitalier Universitaire de Liège - CHU > Unilab > Laboratoire histologie
SEIDEL, Laurence ; Centre Hospitalier Universitaire de Liège - CHU > Département de gestion des systèmes d'informations (GSI) > Secteur d'appui à la recherche clinique et biostatistique
NIKKELS, Arjen ; Centre Hospitalier Universitaire de Liège - CHU > Autres Services Médicaux > Service de dermatologie
Language :
English
Title :
Exploratory Assessment of Oxygen Flow–Assisted Cutaneous Administration of Methotrexate for Superficial Basal Cell Carcinoma, Mycosis Fungoides, and Extramammary Paget Disease
Alternative titles :
[en] Évaluation exploratoire de l'administration cutanée assistée par flux d'oxygène de méthotrexate pour le carcinome basocellulaire superficiel, la mycose fongoïde et la maladie extramammaire de Paget
Arits, A.H., Mosterd, K., Essers, B.A., Spoorenberg, E., Sommer, A., De Rooij, M.J., et al. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. Lancet Oncol 14 (2013), 647–654.
Asel, M., LeBoeuf, N.R., Extramammary Paget's disease. Hematol Oncol Clin North Am 33 (2019), 73–85.
Berthelot, C., Rivera, A., Duvic, M., Skin directed therapy for mycosis fungoides: a review. J Drugs Dermatol 7 (2008), 655–666.
Breneman, D., Duvic, M., Kuzel, T., Yocum, R., Truglia, J., Stevens, V.J., Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma. Arch Dermatol 138 (2002), 325–332.
Demierre, M.F., Vachon, L., Ho, V., Sutton, L., Cato, A., Leyland-Jones, B., Phase 1/2 pilot study of methotrexate-laurocapram topical gel for the treatment of patients with early-stage mycosis fungoides. Arch Dermatol 139 (2003), 624–628.
Geisse, J., Caro, I., Lindholm, J., Golitz, L., Stampone, P., Owens, M., Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 50 (2004), 722–733.
Humme, D., Nast, A., Erdmann, R., Vandersee, S., Beyer, M., Systematic review of combination therapies for mycosis fungoides. Cancer Treat Rev 40 (2014), 927–933.
Jawed, S.I., Myskowski, P.L., Horwitz, S., Moskowitz, A., Querfeld, C., Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol 70 (2014), 205.e1–205.e16 quiz 221.
Jawed, S.I., Myskowski, P.L., Horwitz, S., Moskowitz, A., Querfeld, C., Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions. J Am Acad Dermatol 70 (2014), 223.e1–223.e17 quiz 240.
Lebas, E., Castronovo, C., Arrese, J.E., Libon, F., Tassoudji, N., Seidel, L., et al. Prospective pilot evaluation of the efficacy and safety of topical ingenol mebutate gel for localized patch/plaque stage mycosis fungoides. Open Dermatol J 11 (2017), 98–107.
Lin, Y.K., Huang, Z.R., Zhuo, R.Z., Fang, J.Y., Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int J Nanomed 5 (2010), 117–128.
Martin, A.G., Bexarotene gel: a new skin-directed treatment option for cutaneous T-cell lymphomas. J Drugs Dermatol 2 (2003), 155–167.
Nguyen, H.X., Banga, A.K., Electrically and ultrasonically enhanced transdermal delivery of methotrexate. Pharmaceutics, 10, 2018, 117.
Rook, A.H., Gelfand, J.M., Wysocka, M., Troxel, A.B., Benoit, B., Surber, C., et al. Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma. Blood 126 (2015), 1452–1461.
Roozeboom, M.H., Arits, A.H., Nelemans, P.J., Kelleners-Smeets, N.W., Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials. Br J Dermatol 167 (2012), 733–756.
Sanderson, P., Innamaa, A., Palmer, J., Tidy, J., Imiquimod therapy for extramammary Paget's disease of the vulva: a viable non-surgical alternative. J Obstet Gynaecol 33 (2013), 479–483.
Sawada, M., Kato, J., Yamashita, T., Yoneta, A., Hida, T., Horimoto, K., et al. Imiquimod 5% cream as a therapeutic option for extramammary Paget's disease. J Dermatol 45 (2018), 216–219.
Sidler, M., Fouché, N., Meth, I., von Hahn, F., von Rechenberg, B., Kronen, P.W., Transcutaneous treatment with vetdrop(®) sustains the adjacent cartilage in a microfracturing joint defect model in sheep. Open Orthop J 7 (2013), 57–66.
Sidler, M., Fouché, N., Meth, I., von Hahn, F., von Rechenberg, B., Kronen, P.W., Preliminary study on carprofen concentration measurements after transcutaneous treatment with Vetdrop® in a microfracture joint defect model in sheep. BMC Vet Res, 10, 2014, 268.
Taudorf, E.H., Lerche, C.M., Vissing, A.C., Philipsen, P.A., Hannibal, J., D'Alvise, J., et al. Topically applied methotrexate is rapidly delivered into skin by fractional laser ablation. Expert Opin Drug Deliv 12 (2015), 1059–1069.
Taudorf, E.H., Lerche, C.M., Erlendsson, A.M., Philipsen, P.A., Hansen, S.H., Janfelt, C., et al. Fractional laser-assisted drug delivery: laser channel depth influences biodistribution and skin deposition of methotrexate. Lasers Surg Med 48 (2016), 519–529.
Teslenko A, Gulik D, Von Hahn F inventors; Percutaneous application system. US patent 9,943,671, http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=9,943,671.PN.&OS=PN/9,943,671&RS=PN/9,943,671; 2013 (accessed 17 April 2018).
Trautinger, F., Eder, J., Assaf, C., Bagot, M., Cozzio, A., Dummer, R., et al. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017. Eur J Cancer 77 (2017), 57–74.
Vemulapalli, V., Yang, Y., Friden, P.M., Banga, A.K., Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate. J Pharm Pharmacol 60 (2008), 27–33.
Vena, G.A., Cassano, N., Iannone, F., Update on subcutaneous methotrexate for inflammatory arthritis and psoriasis. Ther Clin Risk Manag 14 (2018), 105–116.
Weberschock, T., Strametz, R., Lorenz, M., Röllig, C., Bunch, C., Bauer, A., et al. Interventions for mycosis fungoides. Cochrane Database Syst Rev, 9, 2012, CD008946.
Wilcox, R.A., Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management. Am J Hematol 92 (2017), 1085–1102.
Wohlrab, J., Neubert, R.H., Michael, J., Naumann, S., Methotrexate for topical application in an extemporaneous preparation. J Dtsch Dermatol Ges 13 (2015), 891–901.
Zackheim, H.S., Kashani-Sabet, M., McMillan, A., Low-dose methotrexate to treat mycosis fungoides: a retrospective study in 69 patients. J Am Acad Dermatol 49 (2003), 873–878.
